Intervention

leucovorin calcium

ClinicalTrials.gov intervention label

Clinical trials10
Recruiting0
Common conditions14
Lead sponsors shown10

Clinical trials

10 shown
Sunitinib Malate and Combination Chemotherapy as Front-Line Therapy in Treating Patients With Metastatic Rectal Cancer That Cannot Be Removed by SurgeryNCT00936832 · 2009-04-01
WITHDRAWN
Stereotactic Radiation, Nelfinavir Mesylate & Neoadjuvant Chemotherapy in Locally Advanced Pancreatic CancerNCT01068327 · 2007-11-05
COMPLETED
Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and/or LungNCT00557102 · 2007-09-01
COMPLETED
Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by SurgeryNCT00513266 · 2007-06-01
UNKNOWN
Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's LymphomaNCT00392834 · 2006-09-01
COMPLETED
AZD2171 and Standard Combination Chemotherapy in Advanced Non-Small Cell Lung Cancer or Colorectal CancerNCT00343408 · 2005-11-29
COMPLETED
Fluorouracil-Uracil and Leucovorin in Treating Women With Metastatic Breast CancerNCT00005608 · 2000-02-01
TERMINATED
Combination Chemotherapy in Treating Older Women With Metastatic Breast CancerNCT00010075 · 2000-01-01
UNKNOWN
Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or LymphomasNCT00019513 · 1998-08-01
COMPLETED
Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's LymphomaNCT00002578 · 1994-08-01
COMPLETED

Trial status mix

COMPLETED6
UNKNOWN2
TERMINATED1
WITHDRAWN1

Phase mix

PHASE27
PHASE13

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.